Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipase Thera-blend is a **dietary supplement** containing a blend of lipase enzymes, specifically designed to aid in the digestion of dietary fats. The Thera-blend™ technology, developed by Enzymedica, combines multiple strains of lipase (including those derived from *Candida rugosa* and *Rhizopus oryzae*) that are active across a broad pH range, allowing for efficient fat breakdown throughout different sections of the digestive tract[6][7]. Its mechanism of action is enzymatic hydrolysis of triglycerides into free fatty acids and glycerol, which supports fat digestion and nutrient absorption, particularly vitamins A, D, E, and K[4]. It is being evaluated in clinical trials for potential benefits in memory among healthy adults and is marketed for digestive support in cases such as pancreatic insufficiency and fat malabsorption[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lipase Thera-blend.